{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:41:51Z","timestamp":1791409311788,"version":"4.3.3"},"reference-count":37,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.biopsych.2004.01.018","type":"journal-article","created":{"date-parts":[[2004,4,10]],"date-time":"2004-04-10T09:39:29Z","timestamp":1081589969000},"page":"1001-1006","source":"Crossref","is-referenced-by-count":112,"title":["Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide"],"prefix":"10.1016","volume":"55","author":[{"given":"Anissa","family":"Abi-Dargham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence S","family":"Kegeles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Zea-Ponce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Mawlawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Mitropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"O'Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold W","family":"Koenigsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Van Heertum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Laruelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry J","family":"Siever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2004.01.018_BIB1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1176\/ajp.155.6.761","article-title":"Increased striatal dopamine transmission in schizophrenia","volume":"155","author":"Abi-Dargham","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB2","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.97.14.8104","article-title":"Increased baseline occupancy of D2 receptors by dopamine in schizophrenia","volume":"97","author":"Abi-Dargham","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB3","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1073\/pnas.94.6.2569","article-title":"Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations","volume":"94","author":"Breier","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-0773.1963.tb01730.x","article-title":"Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain","volume":"20","author":"Carlsson","year":"1963","journal-title":"Acta Pharmacol Toxicol"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00004647-199704000-00009","article-title":"Quantification of amphetamine-induced changes in","volume":"17","author":"Carson","year":"1997","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB6","series-title":"Structured Clinical Interview for Axis I Disorders\u2014Patient Edition","author":"First","year":"1996"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0969-8051(00)00144-X","article-title":"(-)-N-[(11)C]propyl-norapomorphine","volume":"27","author":"Hwang","year":"2000","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB8","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0006-3223(00)00976-8","article-title":"Modulation of amphetamine-induced striatal dopamine release by ketamine in humans","volume":"48","author":"Kegeles","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/(SICI)1098-2396(19990315)31:4<302::AID-SYN9>3.0.CO;2-A","article-title":"Stability of","volume":"31","author":"Kegeles","year":"1999","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB10","first-page":"88","article-title":"In vitro and in vivo evaluation of [123I]IBZM","volume":"30","author":"Kung","year":"1989","journal-title":"J Nucl Med"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00004647-200003000-00001","article-title":"Imaging synaptic neurotransmission with in vivo binding competition techniques","volume":"20","author":"Laruelle","year":"2000","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/jcbfm.1994.56","article-title":"SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in nonhuman primates. II. Equilibrium analysis of constant infusion experiments and correlation with in vitro parameters","volume":"14","author":"Laruelle","year":"1994","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0006-3223(99)00067-0","article-title":"Increased dopamine transmission in schizophrenia","volume":"46","author":"Laruelle","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB14","doi-asserted-by":"crossref","first-page":"9235","DOI":"10.1073\/pnas.93.17.9235","article-title":"Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug free schizophrenic subjects","volume":"93","author":"Laruelle","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB15","first-page":"1182","article-title":"SPECT imaging of striatal dopamine release after amphetamine challenge","volume":"36","author":"Laruelle","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0893-133X(97)00043-2","article-title":"Imaging D-2 receptor occupancy by endogenous dopamine in humans","volume":"17","author":"Laruelle","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-2396(199701)25:1<1::AID-SYN1>3.0.CO;2-H","article-title":"Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates","volume":"25","author":"Laruelle","year":"1997","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB18","first-page":"743","article-title":"Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjects","volume":"35","author":"Laruelle","year":"1994","journal-title":"J Nucl Med"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB19","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1176\/appi.ajp.159.7.1190","article-title":"MRI study of caudate nucleus volume and its cognitive correlates in neuroleptic-naive patients with schizotypal personality disorder","volume":"159","author":"Levitt","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB20","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0306-4522(91)90003-7","article-title":"Distribution of dopaminergic receptors in the primate cerebral cortex","volume":"40","author":"Lidow","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB21","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF00216006","article-title":"Provocative tests with psychostimulant drugs in schizophrenia","volume":"91","author":"Lieberman","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s007020170073","article-title":"A consideration of the dopamine D2 receptor monomer-dimer equilibrium and the anomalous binding properties of the dopamine D2 receptor ligand, N-methyl spiperone","volume":"108","author":"Logan","year":"2001","journal-title":"J Neural Transm"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00004647-200303000-00004","article-title":"Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II","volume":"23","author":"Martinez","year":"2003","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0006-3223(01)01089-7","article-title":"Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression","volume":"50","author":"Parsey","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB25","series-title":"Structured Interview for the Diagnosis of DSM-III-R Personality Disorders","author":"Pfoh","year":"1989"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB26","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ana.10526","article-title":"Endogenous dopamine release after pharmacological challenges in Parkinson's disease","volume":"53","author":"Piccini","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB27","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.1145194","article-title":"Antipsychotic drugs","volume":"188","author":"Seeman","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB28","first-page":"1964","article-title":"Dynamic SPECT imaging of D2 receptors in human subjects with iodine-123-IBZM","volume":"33","author":"Seibyl","year":"1992","journal-title":"J Nucl Med"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB29","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/archpsyc.58.9.877","article-title":"Striatal size and relative glucose metabolic rate in schizotypal personality disorder and schizophrenia","volume":"58","author":"Shihabuddin","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB30","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1176\/ajp.148.9.1246","article-title":"Plasma homovanillic acid in schizotypal personality disorder","volume":"148","author":"Siever","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1176\/ajp.150.1.149","article-title":"CSF homovanillic acid in schizotypal personality disorder","volume":"150","author":"Siever","year":"1993","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0920-9964(01)00363-2","article-title":"Cognitive and brain function in schizotypal personality disorder","volume":"54","author":"Siever","year":"2002","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB33","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0006-8993(99)01834-X","article-title":"Is synaptic dopamine concentration the exclusive factor which alters the in vivo binding of [11C]raclopride? PET studies combined with microdialysis in conscious monkeys","volume":"841","author":"Tsukada","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB34","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/(SICI)1098-2396(19990915)33:4<268::AID-SYN3>3.0.CO;2-W","article-title":"GBR12909 attenuates amphetamine-induced striatal dopamine release as measured by [(11)C]raclopride continuous infusion PET scans","volume":"33","author":"Villemagne","year":"1999","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB35","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00004728-199605000-00020","article-title":"MR-PET image coregistration for quantitation of striatal dopamine D2 receptors","volume":"20","author":"Wang","year":"1996","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB36","unstructured":"Weinberger DR, Laruelle M (2001): Neurochemical and neuropharmacological imaging in schizophrenia. In: Nemeroff C, editor. Neuropharmacology\u2014The Fifth Generation of Progress, vols. 883\u2013885. New York: Lippincott, Williams and Wilkins"},{"key":"10.1016\/j.biopsych.2004.01.018_BIB37","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0969-8051(99)00031-1","article-title":"Synthesis of [123I]IBZM","volume":"26","author":"Zea-Ponce","year":"1999","journal-title":"Nucl Med Biol"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322304001040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322304001040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T20:25:55Z","timestamp":1734294355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322304001040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0006322304001040"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2004.01.018","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}